ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

argenx at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

argenx brings 5 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 1717. Its program centres on myositis and Sjögren's disease, including phase 2 data for efgartigimod PH20 SC in active inflammatory myopathy and real-world studies of treatment patterns and the patient journey.

OrganizationACR Convergence 2026 Attendance
Biotech companies
A biotechnology company developing antibody-based medicines for autoimmune diseases.
Booth
Exhibiting at Booth 1717
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Industry
Mon Nov 9
5:30pm–7:30pm
Autoimmune Myositis Reframed: New Perspectives on Burden, Biology and Clinical Outcomes
Hyatt Regency Orlando, Regency Ballroom Q
Myositis · with Johns Hopkins University, University of California, Los Angeles
Industry
Tue Nov 10
5:30pm–7:30pm
IIMagine What’s Next in Myositis Care: Integrating Targeted Strategies to Advance Patient Outcomes
Hyatt Regency Orlando, Regency Ballroom P
Myositis · with University of Pittsburgh, Johns Hopkins University

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at argenx

Tell us what you sell and we’ll find the people at argenx most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction